7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Addison Disease D000224 3 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Hirsutism D006628 3 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Mastocytoma D034801 3 associated lipids
Progeria D011371 3 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Hearing Loss D034381 3 associated lipids
Periapical Granuloma D010484 3 associated lipids
Respirovirus Infections D010253 3 associated lipids
Osteitis Deformans D010001 3 associated lipids
Measles D008457 3 associated lipids
Malocclusion D008310 3 associated lipids
Hyperparathyroidism D006961 3 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Mitral Valve Stenosis D008946 3 associated lipids
Periapical Diseases D010483 4 associated lipids
Tinnitus D014012 4 associated lipids
Diabetes Complications D048909 4 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Fractures, Bone D050723 4 associated lipids
Hyperparathyroidism, Secondary D006962 4 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Jaw Diseases D007571 4 associated lipids
Osteoarthritis D010003 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Hypercalciuria D053565 4 associated lipids
Paraneoplastic Syndromes D010257 4 associated lipids
Biliary Atresia D001656 4 associated lipids
Endocrine System Diseases D004700 4 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Mitral Valve Insufficiency D008944 4 associated lipids
Osteoarthritis, Hip D015207 4 associated lipids
Temporomandibular Joint Disorders D013705 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
beta-Thalassemia D017086 5 associated lipids
Bone Neoplasms D001859 5 associated lipids
Calcinosis D002114 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Femur Head Necrosis D005271 5 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hot Flashes D019584 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Middleton K et al. Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. 2017 J Biomech pmid:28552413
Lu LY et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. 2017 J. Orthop. Res. pmid:28248001
Kuroyanagi G et al. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2017 Prostaglandins Other Lipid Mediat. pmid:28163121
Choi EM et al. Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. 2017 Environ. Toxicol. pmid:28836330
Ozaki Y et al. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. 2017 PLoS ONE pmid:28937990
Tschiderer L et al. Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. 2017 PLoS ONE pmid:28837646
Åšliwicka E et al. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. 2017 PLoS ONE pmid:28732027
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Spirlandeli AL et al. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. 2017 Clinics (Sao Paulo) pmid:28492723
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Songia P et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. 2017 Oxid Med Cell Longev pmid:28261377
Jia J et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. 2017 Mol Med Rep pmid:28260003
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Hanmoto T et al. Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. 2017 Biomed. Res. pmid:28239034
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Xiong L et al. Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. 2017 J. Cell Biol. pmid:28193701
Sponder M et al. Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. 2017 BMC Cardiovasc Disord pmid:28056805
Hygum K et al. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. 2017 Eur. J. Endocrinol. pmid:28049653
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854

Table of Content